Skip to main content
Caplight Logo









Scilife

Scilife

Private
BrusselsHealthcare & Life Scienceshttps://www.scilife.io/

Last Round

Growth Equity

Jun 7, 2024

Company Overview

Scilife operates in Healthcare & Life Sciences and is based in Brussels. Its latest recorded funding round was a Growth Equity round in June 2024.

Scilife is a SaaS company that provides a smart quality management system designed to automate and streamline compliance and quality processes for life sciences organizations.

Sector

Healthcare & Life Sciences

Verticals

Quality Management, Compliance & Risk, Vertical SaaS, Document Management, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Freemium

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Scilife Comparables

Compare Scilife with similar companies based on industry and business-model similarity.

Scilife comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qualio
93%
Dot Compliance
91%
ZenQMS
89%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Scilife Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityJun 7, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Sebastien Sepierre

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Scilife Investors

Notable investors and investment history

Scilife investors
InvestorRounds
Five Elms CapitalGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2025

    Grew 18% QoQ, from 83 to 98 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Scilife Filings

Explore SEC and related filing metadata, where available.

Scilife filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Scilife's valuation, stock price, and market status.

Is Scilife a public or private company?

Scilife is a private company.

What is the current stock price of Scilife?

Scilife is a private company, so its shares have no public market price. Caplight tracks Scilife's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Scilife worth (valuation)?

Valuation information for Scilife is not publicly available.

Can I buy Scilife stock?

Scilife shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Scilife's last funding round?

Scilife's most recent funding round was Growth Equity on June 7, 2024.

Who are the main investors in Scilife?

Key investors in Scilife include Five Elms Capital.

Will Scilife IPO soon?

No public IPO plans have been announced for Scilife.

How can I track Scilife secondary market activity?

Caplight tracks bids, offers, and trades in Scilife's shares on secondary markets.

Firmographic Details

HeadquartersBrussels
Employee Range81
Year Founded2017
Last FundingJun 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?